Pharmafile Logo
Pharmafocus logo
Advanced Search
teva_copy

Teva and Active Biotech hit by Phase 3 drug failure

May 8, 2017
Research and Development, Sales and Marketing Active Biotech, Teva

Teva and Active Biotech have been collaborating on the drug laquinimod since 2004 but it now looks like the work put …

News
scale-403585_960_720

Weight loss pill treatment rejected by NICE

May 8, 2017
Medical Communications, Sales and Marketing NICE, orexigen

NICE has announced, in an Appraisal Consultation Document, that it is not able to recommend Orexigen’s Mysimba as a weight …

News
office-space-1988480_960_720

Board battle scuppers Seattle Genetics’ $2 billion licensing deal

May 8, 2017
Sales and Marketing Immunomedics, Seattle Genetics, venBio

In another example of the influence that activist investors can have on the direction of a business, the potentially $2 …

News

NHS staff feeling the pay squeeze, reports NHS Providers

May 8, 2017
Medical Communications, Sales and Marketing NHS, NHS Providers

NHS Providers, the membership organisation and trade association for the NHS, has laid a stark warning at the door of …

News

FDA approves first new treatment for ALS in two decades

May 8, 2017
Sales and Marketing MLS, Mitsubishi Tanabe Pharma America, Radicava

The FDA has approved only the second form of treatment for amyotrophic lateral sclerosis (ALS), with the previous drug, riluzole, …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday again, and today marks the press date of the latest edition of Pharmafile, our bi-annual life sciences market …

News

Pfizer offers breast cancer drug for free following NICE rejection

May 5, 2017
Medical Communications, Sales and Marketing NICE, Pfizer

Following NICE’s decision rejecting Pfizer’s breast cancer therapy Ibrance (palbociclib) for use on the NHS, the manufacturer has announced that …

News
exit-1722888_960_720

Regulus CEO heads to exit as company struggles with FDA hold

May 5, 2017
Medical Communications, Research and Development Regulus, hepatitis C

Regulus seemed to be in a good place just last year as its lead drug candidate performed well in a …

News
talc_mine

J&J chalks up another defeat in $110 million talc-cancer case

May 5, 2017
Medical Communications Johnson & Johnson, baby powder

Johnson & Johnson has suffered another defeat in a lawsuit against its talcum powder product. The latest case stands as …

News
gsk_hq_logo

GSK boosts Benlysta production with $139 million investment

May 5, 2017
Manufacturing and Production, Medical Communications GSK

GSK has announced that it will invest $139 million into increasing production capacity at its Rockville, Maryland, site. The manufacturing …

News
running-573762_960_720

‘Exercise pill’ boosts endurance by 70% in mice

May 4, 2017
Research and Development

A study by the Salk Institute found that mice that were given a chemical compound, named GW1517 (GW), were able …

News
european_commission_web

European Commission warns UK over drug authorisation validity due to Brexit

May 4, 2017
Medical Communications, Sales and Marketing EMA, European Commission, brexit

The European Commission has issued a warning to pharmaceutical firms in the UK over the validity of current and future …

News
world_health_organization_flag

WHO aims to increase uptake of biosimilars in poorer countries

May 4, 2017
Medical Communications, Research and Development Cancer, Roche, WHO, biosimilars

The WHO has announced that it will launch a project to prequalify biosimilar medicines for the treatment of certain cancers. …

News
roche

Roche denies its acne treatment led to suicide of 21 year old

May 4, 2017
Medical Communications, Sales and Marketing Roaccutane, Roche

Last month, Luke Reeves took his own life at the age of just 21. Prior to his death, he had …

News
blood-1813410_960_720

Cheap blood test may help tailor prostate cancer treatment

May 4, 2017
Research and Development Blood test, prostate cancer

A blood test that costs less than £50 to perform could prevent men from undergoing treatment with two drugs that …

News
shutterstock_243110086

Real-world data: High on the life science agenda

May 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing real world data, real-world data

John Wise of The Pistoia Alliance discusses the necessity of real-world data for a prosperous future for the life sciences …

Feature
shutterstock_159488225

Researchers identify key trigger in melanoma progression

May 3, 2017
Research and Development melanoma

Researchers from life sciences research institute VIB and KU Leuven in Belgium in collaboration with INSERM, the French National Institute …

News
shutterstock_141299494

Study discovers origin of cancer metastases and why they reoccur

May 3, 2017
Research and Development Cancer, metastases

A team of scientists from The Scripps Research Institute (TSRI) have discovered the secrets of where metastases originate and why …

News
ketmine_injection_i

First large-scale study gives hope for ketamine as a depression therapy

May 3, 2017
Research and Development Ketamine, depression, mental health

While the development of truly innovative mental health therapies has ground to a halt somewhat, scientific research in the field …

News

NICE recommends Janssen’s first-of-its-kind Crohn’s drug Stelara

May 3, 2017
Research and Development, Sales and Marketing Crohn’s disease, Janssen, NICE, Stelara, crohn's disease

Janssen has announced that it has secured recommendation from NICE for Stelara (ustekinumab) in the indication of moderately to severely …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026